Endometrial undifferentiated carcinoma
MONDO:0006199A primary carcinoma of the endometrium characterized by the presence of malignant cells that lack evidence of differentiation.
Also known as: endometrial undifferentiated carcinoma, undifferentiated endometrial carcinoma
2855 clinical trials for this condition and its sub-types, 9 tagged with Endometrial undifferentiated carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Hormone blockers join forces against Treatment-Resistant endometrial cancer
Disease control CompletedThis phase II trial tests whether combining two hormone-blocking drugs — onapristone and anastrozole — can shrink tumors or slow cancer growth in women with hormone-receptor-positive endometrial cancer that has not responded to prior chemotherapy. Onapristone blocks progesterone …
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control CompletedThis phase II trial tested whether combining two drugs, pembrolizumab and olaparib, could help people with persistent or recurrent endometrial cancer or carcinosarcoma. The study enrolled 26 participants and looked at how many responded to treatment and what side effects occurred…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Shorter radiation after hysterectomy shows promise for endometrial cancer
Disease control CompletedThis study tested a shorter course of pelvic radiation (about 1 week instead of the usual 5-6 weeks) given after hysterectomy for advanced endometrial cancer. The goal was to see if this shorter treatment causes fewer side effects while still controlling the cancer. The study inc…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC